| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 4 | |
| #2 | Canada | 4 | |
| #3 | China | 4 | |
| #4 | EPO (European Patent Office) | 4 | |
| #5 | Israel | 4 | |
| #6 | Taiwan | 4 | |
| #7 | United States | 4 | |
| #8 | WIPO (World Intellectual Property Organization) | 4 | |
| #9 | Brazil | 3 | |
| #10 | Republic of Korea | 3 | |
| #11 | Singapore | 3 | |
| #12 | Philippines | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Syringes | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Quinn Deborah | 36 |
| #2 | Shah Parag | 36 |
| #3 | Dekker Martin | 10 |
| #4 | Parag Shah | 3 |
| #5 | Deborah Quinn | 3 |
| #6 | Martin Dekker | 1 |
| Publication | Filing date | Title |
|---|---|---|
| SG11202005975XA | Pulsed administration of inhaled nitric oxide for the treatment of pulmonary hypertension | |
| SG11202005974YA | Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension | |
| US2020188319A1 | Use Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension Associated With Lung Disease |